West Pharmaceutical Services WST Return on equity

Return on equity at other companies

Becton, Dickinson and CompanyBDX

4.6%-1.3pp

AptarGroupATR

15%-0.2pp

Halozyme TherapeuticsHALO

124.5%+12.7pp

AVT

AvantorAVTR

-10.6%-22.3pp

DowDOW

-6.7%+3.4pp

DuPont de Nemours, Inc.DD

-0.2%-0.1pp

FAQ

What is West Pharmaceutical Services's return on equity?

West Pharmaceutical Services (WST) reported return on equity of 19.1% in Q2 2026.

How has West Pharmaceutical Services's return on equity changed year-over-year?

West Pharmaceutical Services's return on equity increased by 7.7% year-over-year, from 17.7% to 19.1%.

What is the long-term trend for West Pharmaceutical Services's return on equity?

Over 5 years (2020 to 2025), West Pharmaceutical Services's return on equity has grown at a -3.6% compound annual growth rate (CAGR), from 20.2% to 16.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.